) The Breast Cancer Program is integrated and comprehensive spanning basic, translational and clinical research. One area of basic research is focused on understanding the biology of the MCF10AT model of human preneoplastic, proliferative breast disease, which was developed by members of this Program. This xenograft model recapitulates the histological stigmata of early breast cancer development: atypical hyperplasia (AH), carcinoma in situ (CIS) with progression to invasive cancer. Estrogen enhances, and tamoxifen inhibits, both AH and CIS. Translational research utilizes this model as a preclinical test system of prevention agents and strategies. This work is part of an interprogrammatic collaboration with the Molecular Biology and Genetics and the Population Studies and Prevention Programs, ultimately aimed at testing prevention approaches in the community-research setting. Current emphasis is on control of breast cancer risk by dietary modification and chemoprevention. A second area of basic research is steroid and peptide signaling factors and receptors in breast cancer growth and development and the interface of these factors/receptors with each other and in epithelial-stromal interactions. Translational/clinical research efforts are also directed towards development of more efficacious therapy for breast cancer patients. Goals include development of effective biological/immunological based therapy, elucidation of the parameters that lead to a favorable outcome of high dose chemotherapy with autologous stem cell transplantation, and integration of biological therapy into the high dose setting. Basic/translational research in these areas is focused on vaccine development, on in vitro immunization for adoptive immunotherapy and on mechanisms of treatment failure. These studies form the foundation of ongoing and planned clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-22
Application #
6457225
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1988-04-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
22
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Bock, Cathryn H; Jay, Allison M; Dyson, Gregory et al. (2018) The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Res Treat 167:741-749
Hastert, T A; de Oliveira Otto, M C; LĂȘ-Scherban, F et al. (2018) Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the Multi-Ethnic Study of Atherosclerosis. Int J Obes (Lond) 42:433-440
Park, Hyo K; Schildkraut, Joellen M; Alberg, Anthony J et al. (2018) Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control 29:1081-1091
Heyza, Joshua; Lei, Wen; Watza, Donovan et al. (2018) Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clin Cancer Res :
Mittal, Sandeep; Klinger, Neil V; Michelhaugh, Sharon K et al. (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414-421
Su, Yongwei; Li, Xinyu; Ma, Jun et al. (2018) Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochem Pharmacol 148:13-26
Bonomi, Robin; Popov, Vadim; Laws, Maxwell T et al. (2018) Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [18F]-2-Fluorobenzoylaminohexanoicanilide. J Med Chem 61:7116-7130
Paximadis, Peter; Beebe-Dimmer, Jennifer L; George, Julie et al. (2018) Comparing Treatment Strategies for Stage I Small-cell lung Cancer. Clin Lung Cancer 19:e559-e565
Modi, Dipenkumar; Al-Kadhimi, Zaid; Chen, Wei et al. (2018) A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation. Am J Hematol 93:E96-E98
Patki, Mugdha; McFall, Thomas; Rosati, Rayna et al. (2018) Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Sci Rep 8:16006

Showing the most recent 10 out of 826 publications